Oral immunotherapy: Ready for prime time?

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 1, 2011, Pages 289-290

  Katz, Yitzhak ^a,b   Goldberg, Michael R ^a   Stein, Miguel ^a   Levy, Michael ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ALLERGIC RHINITIS; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; LETTER; MORBIDITY; MORTALITY; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REIMBURSEMENT; SUBCUTANEOUS IMMUNOTHERAPY;

ADMINISTRATION, ORAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; FOOD HYPERSENSITIVITY; HUMANS;

EID: 78650855414     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.08.053     Document Type: Letter

References (3)

1. A. Thyagarajan, P. Varshney, S.M. Jones, S. Sicherer, R. Wood, and B.P. Vickery Peanut oral immunotherapy is not ready for clinical use J Allergy Clin Immunol 126 2010 31 32
2. D. Atkins, and S.A. Bock Fatal anaphylaxis to foods: epidemiology, recognition and prevention Curr Allergy Asthma Rep 3 2009 179 185
3. A.J. Frew Allergen immunotherapy J Allergy Clin Immunol 125 2010 S306 S313